Holen Sie sich die Stockscreener-App
28.12
5.24%
1.40
Vorhandelsmarkt:
28.27
0.15
+0.53%
Schlusskurs vom Vortag:
$26.72
Offen:
$26.99
24-Stunden-Volumen:
612.32K
Relative Volume:
0.65
Marktkapitalisierung:
$2.95B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.00%
1M Leistung:
+9.63%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$26.12
$29.20
1-Wochen-Bereich:
$25.47
$29.78
52-Wochen-Spanne:
$12.30
$32.81
Metsera Inc Stock (MTSR) Company Profile
Firmenname
Metsera Inc
Sektor
Branche
Telefon
(212) 784-6595
Adresse
3 WORLD TRADE CENTER, NEW YORK
Vergleichen Sie MTSR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTSR
Metsera Inc
|
28.12 | 2.92B | 0 | 0 | 0 | 0.00 |
|
ONC
Beone Medicines Ltd Adr
|
245.93 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.43 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.415 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.10 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.81 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Metsera Inc Stock (MTSR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-25 | Eingeleitet | BofA Securities | Buy |
| 2025-02-25 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-25 | Eingeleitet | Guggenheim | Buy |
Metsera Inc Aktie (MTSR) Neueste Nachrichten
Rising Leaders 2025: Metsera’s Whit Bernard’s Musical Path To Biotech Leadership - insights.citeline.com
Metsera (NASDAQ:MTSR) Trading Down 6.9% – Here’s What Happened - Defense World
Cantor Fitzgerald maintains overweight on Metsera shares By Investing.com - Investing.com India
Cantor Fitzgerald maintains overweight on Metsera shares - Investing.com
Viking among notable gainers as Pfizer raises deal prospects - MSN
Two new option listings and two option delistings on May 22nd - TipRanks
Metsera Inc (NASDAQ: MTSR) Shares Rose Recently, But Trouble Could Still Be Around The Corner. - Stocksregister
Transcript : Metsera, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 02 - marketscreener.com
Decoding Metsera Inc (MTSR): A Strategic SWOT Insight - GuruFocus
Metsera's Q1 Net Loss Narrows - marketscreener.com
Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress - The Manila Times
Metsera, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Metsera: A Must-Add To Your Watchlist Thanks To GLP-1 Obesity Promise (NASDAQ:MTSR) - Seeking Alpha
Metsera to Present at Bank of America 2025 Global Healthcare Conference - The Manila Times
Metsera Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Metsera Rings the Opening Bell - Nasdaq
Metsera Inc’s Market Journey: Closing Weak at 22.74, Down -5.17 - DWinneX
MTSR Shares Experience Surge in Value - knoxdaily.com
Nothing is Better Than Metsera Inc (MTSR) stock at the moment - Sete News
Viking stock rises as Pfizer ups deal prospects (VKTX:NASDAQ) - Seeking Alpha
Metsera Inc. appoints new director and legal officer By Investing.com - Investing.com India
Metsera Inc. appoints new director and legal officer - Investing.com
A Guide To The Risks Of Investing In Metsera Inc (MTSR) - knoxdaily.com
Metric Analysis: Metsera Inc (MTSR)’s Key Ratios in the Limelight - DWinneX
A Closer Look at Metsera Inc (MTSR) Stock Gains - investchronicle.com
Metsera Inc (MTSR) stock analysis: A simple moving average approach - uspostnews.com
Metsera, Inc. Appoints New Board Member and Legal Officer - TipRanks
Metsera (NASDAQ:MTSR) Shares Gap Up – Time to Buy? - Defense World
Now Is The Time To Build A Position In Metsera Inc (NASDAQ:MTSR) - Marketing Sentinel
Metsera Inc [MTSR] Director makes an insider purchase of 2,222,222 shares worth 40.0 million. - knoxdaily.com
The Psychology of Metsera Inc Inc. (MTSR) Price Performance: Understanding Market Sentiment - investchronicle.com
Taking the lead: Metsera Inc (MTSR) - Sete News
Financial Metrics Exploration: Understanding Metsera Inc (MTSR) Through Ratios - DWinneX
How did Metsera Inc (MTSR) fare last session? - uspostnews.com
MetaVia’s ‘Safe’ Obesity Drug Resonates With Analysts, But Not Investors - insights.citeline.com
Lilly stock up rallying Structure and Metsera (GPCR:NASDAQ) - Seeking Alpha
Viking, Structure, Metsera on a tear as Pfizer drops obesity pill - MSN
Viking stock on a tear after Pfizer setback (VKTX:NASDAQ) - Seeking Alpha
Is it possible to buy Metsera Inc(MTSR) shares at a good price now? - uspostnews.com
Q1 IPOs Rise From Q4, But Unstable Markets Could Slow New Offerings - insights.citeline.com
Metsera plunges 44% after InvestingPro’s overvaluation warning By Investing.com - Investing.com South Africa
Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025 - Endpoints News
Metsera sees cash runway into 2027 - TipRanks
Metsera reports Q4 EPS ($3.52) vs. (94c) last year - TipRanks
Finanzdaten der Metsera Inc-Aktie (MTSR)
Es liegen keine Finanzdaten für Metsera Inc (MTSR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
6.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):